Status:
NOT_YET_RECRUITING
Cohort Project of Patients With Inflammatory Rheumatism
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Rheumatoid Arthritis
Spondyloarthritis, Axial
Eligibility:
All Genders
18+ years
Brief Summary
Chronic inflammatory rheumatism (CIR) is a group of inflammatory diseases that affect the joints and spine and are related to an abnormal immune response. CIR includes many different forms of arthriti...
Eligibility Criteria
Inclusion
- Patient over 18 years of age.
- Patients with rheumatoid arthritis meeting ACR/EULAR criteria or axial and/or peripheral spondyloarthritis meeting ASAS criteria.
- Patients who have failed or are intolerant of DMARDs (methotrexate or arava) for rheumatoid arthritis.
- Patients who have failed treatment with at least two NSAIDs for spondyloarthritis.
- Patients who require biologic/synthetic therapy or patients already receiving biologic or synthetic therapy.
Exclusion
- \- Patient under curatorship.
Key Trial Info
Start Date :
September 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2043
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06059430
Start Date
September 20 2023
End Date
December 20 2043
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nice University Hospital
Nice, France, 06000